np event 2254995 0E193A 1 1
Saturday, September 20th, 2025
2:00pm – 3:00pm PDT
Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)
CME/CE Symposium in Conjunction with the Congress of Clinical Rheumatology West
Live and Livestreamed

Date/Time

Saturday, September 20th, 2025
2:00pm – 3:00pm PDT

Location

Hyatt Regency Huntington Beach
Grand Ballroom
21500 Pacific Coast Highway
Huntington Beach, CA 92648
*Also a live streamed option

Who Should Attend

Rheumatologists and other healthcare professionals who manage patients with SLE

Accreditation Statement

Joint

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Financial Support

This activity has been supported by an independent educational grant from Bristol Myers Squibb.

Faculty

Joan T. Merrill, MD
Joan T. Merrill, MD
Oklahoma Medical Research Foundation
Oklahoma City, OK

Event Details

CE Inquiries/Special Needs

*This symposium is not part of the official Congress of Clinical Rheumatology Meeting.

Provided by

AcademicLogo
1

Review the pathophysiology and mode of action of CAR T-cell therapy.

2

Review the current clinical options, unmet needs, and emerging therapies for patients with severe, refractory systemic lupus erythematosus.

3

Analyze the clinical trial data and clinical applications of CAR T-cell therapy to treat patients with severe, refractory SLE.

4

Develop strategies to incorporate patient shared decision making when discussing CAR T-cell therapy for SLE.

Faculty

Joan T. Merrill, MD
Joan T. Merrill, MD
Oklahoma Medical Research Foundation
Oklahoma City, OK
1

Review Clinical Options for the Management of Patients with Severe, Refractory SLE

2

Pathophysiology and Mode of Action of CAR T-cell Therapies for Autoimmune Disorders

3

Analyze the Current Clinical Trial Data for CAR T-cell Therapies to Treat Patients with Severe, Refractory SLE

4

Review Applications and Logistics of CAR T-cell Treatments and Patient Education

Faculty

Joan T. Merrill, MD
Joan T. Merrill, MD
Oklahoma Medical Research Foundation
Oklahoma City, OK

Event Registration